Skip to main content
Clinical Trials/NCT01273701
NCT01273701
Unknown
Not Applicable

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

National Taiwan University Hospital1 site in 1 country60 target enrollmentJanuary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amphetamine Abuse
Sponsor
National Taiwan University Hospital
Enrollment
60
Locations
1
Primary Endpoint
Endpoint abstinence rate
Last Updated
15 years ago

Overview

Brief Summary

The hospital where this study will be conducted is responsible for the one-year contingency management treatment for methamphetamine drug offenders referred from the Yunlin District Prosecutors Office. Completing the one-year treatment is prerequisite for offenders to get slow prosecutions.

It is an open-label, parallel-group trial comparing the combination of psychosocial intervention and slow prosecutions with psychosocial intervention alone in treating subjects with methamphetamine dependence

Study Hypothesis

  1. Psychosocial interventions in combination with slow prosecutions is more effective than psychosocial interventions alone to achieve abstinence for subjects with methamphetamine abuse/dependance.
  2. Inclusion of telephone reminding before each visit will enhance the retention rate and abstinence rate.
Registry
clinicaltrials.gov
Start Date
January 2011
End Date
December 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • DSM-IV-TR criteria for amphetamine/methamphetamine abuse or dependence
  • 18 - 65 years old
  • For TSTSU-N and TSTSU-T arms: methamphetamine offenders referred by the Yunlin District Prosecutors Office
  • For OPD arm: psychiatric outpatients referred from the psychiatry clinics in National Taiwan University Hospital, Yunlin Branch

Exclusion Criteria

  • Concurrent use of other illicit substances
  • Co-morbidity with major psychotic disorders (schizophrenia, schizoaffective disorder, other psychotic disorder), mental retardation, acute episodes of major depressive disorder or bipolar affective disorder) or serious personality disorders.

Outcomes

Primary Outcomes

Endpoint abstinence rate

Time Frame: At the end of one-year treatment

According to the urine amphetamine/methamphetamine screen after the one-year treatment, negative result suggests successful abstinence.

Secondary Outcomes

  • Retention rate(during the whole one-year treatment)
  • Length of retention(during the whole one-year treatment)
  • The longest period of abstinence(during the whole one-year treatment)

Study Sites (1)

Loading locations...

Similar Trials